1. Home
  2. TLPH

as 03-12-2025 3:44pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Founded: 2005 Country:
United States
United States
Employees: N/A City: SAN MATEO
Market Cap: 9.6M IPO Year: 2011
Target Price: $4.50 AVG Volume (30 days): 48.2K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.66 EPS Growth: N/A
52 Week Low/High: $0.50 - $1.27 Next Earning Date: 03-18-2025
Revenue: $281,000 Revenue Growth: -24.05%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

TLPH Daily Stock ML Predictions

Share on Social Networks: